vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and WYNDHAM HOTELS & RESORTS, INC. (WH). Click either name above to swap in a different company.
WYNDHAM HOTELS & RESORTS, INC. is the larger business by last-quarter revenue ($334.0M vs $205.4M, roughly 1.6× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -18.0%, a 26.2% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -76.3%). WYNDHAM HOTELS & RESORTS, INC. produced more free cash flow last quarter ($168.0M vs $122.4M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -4.6%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Wyndham Hotels & Resorts, Inc., is an American hospitality company based in Parsippany, New Jersey, United States. It describes itself as the largest hotel franchisor in the world, with 9,100 locations.
COLL vs WH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $334.0M |
| Net Profit | $17.0M | $-60.0M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | — |
| Net Margin | 8.3% | -18.0% |
| Revenue YoY | 12.9% | -76.3% |
| Net Profit YoY | 35.3% | -170.6% |
| EPS (diluted) | $0.48 | $-0.80 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $334.0M | ||
| Q4 25 | $205.4M | $334.0M | ||
| Q3 25 | $209.4M | $382.0M | ||
| Q2 25 | $188.0M | $397.0M | ||
| Q1 25 | $177.8M | $316.0M | ||
| Q4 24 | $181.9M | $336.0M | ||
| Q3 24 | $159.3M | $396.0M | ||
| Q2 24 | $145.3M | $367.0M |
| Q1 26 | — | $-60.0M | ||
| Q4 25 | $17.0M | $-60.0M | ||
| Q3 25 | $31.5M | $105.0M | ||
| Q2 25 | $12.0M | $87.0M | ||
| Q1 25 | $2.4M | $61.0M | ||
| Q4 24 | $12.5M | $85.0M | ||
| Q3 24 | $9.3M | $102.0M | ||
| Q2 24 | $19.6M | $86.0M |
| Q1 26 | — | — | ||
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 29.6% | -11.4% | ||
| Q3 25 | 29.7% | 46.6% | ||
| Q2 25 | 18.7% | 37.8% | ||
| Q1 25 | 12.2% | 35.4% | ||
| Q4 24 | 20.9% | 38.4% | ||
| Q3 24 | 21.9% | 43.2% | ||
| Q2 24 | 32.7% | 39.5% |
| Q1 26 | — | -18.0% | ||
| Q4 25 | 8.3% | -18.0% | ||
| Q3 25 | 15.0% | 27.5% | ||
| Q2 25 | 6.4% | 21.9% | ||
| Q1 25 | 1.4% | 19.3% | ||
| Q4 24 | 6.9% | 25.3% | ||
| Q3 24 | 5.9% | 25.8% | ||
| Q2 24 | 13.5% | 23.4% |
| Q1 26 | — | $-0.80 | ||
| Q4 25 | $0.48 | $-0.77 | ||
| Q3 25 | $0.84 | $1.36 | ||
| Q2 25 | $0.34 | $1.13 | ||
| Q1 25 | $0.07 | $0.78 | ||
| Q4 24 | $0.36 | $1.06 | ||
| Q3 24 | $0.27 | $1.29 | ||
| Q2 24 | $0.52 | $1.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $64.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $468.0M |
| Total Assets | $1.7B | $4.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $64.0M | ||
| Q4 25 | $386.7M | $64.0M | ||
| Q3 25 | $285.9M | $70.0M | ||
| Q2 25 | $222.2M | $50.0M | ||
| Q1 25 | $197.8M | $48.0M | ||
| Q4 24 | $162.8M | $103.0M | ||
| Q3 24 | $120.0M | $72.0M | ||
| Q2 24 | $271.6M | $70.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.5B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | — | $2.5B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $2.4B | ||
| Q2 24 | — | $2.4B |
| Q1 26 | — | $468.0M | ||
| Q4 25 | $301.7M | $468.0M | ||
| Q3 25 | $274.8M | $583.0M | ||
| Q2 25 | $232.2M | $570.0M | ||
| Q1 25 | $234.4M | $579.0M | ||
| Q4 24 | $228.8M | $650.0M | ||
| Q3 24 | $234.3M | $583.0M | ||
| Q2 24 | $216.6M | $623.0M |
| Q1 26 | — | $4.2B | ||
| Q4 25 | $1.7B | $4.2B | ||
| Q3 25 | $1.6B | $4.3B | ||
| Q2 25 | $1.6B | $4.3B | ||
| Q1 25 | $1.6B | $4.2B | ||
| Q4 24 | $1.7B | $4.2B | ||
| Q3 24 | $1.6B | $4.2B | ||
| Q2 24 | $1.1B | $4.2B |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.37× | ||
| Q3 25 | — | 4.43× | ||
| Q2 25 | — | 4.44× | ||
| Q1 25 | — | 4.29× | ||
| Q4 24 | — | 3.72× | ||
| Q3 24 | — | 4.19× | ||
| Q2 24 | — | 3.83× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $367.0M |
| Free Cash FlowOCF − Capex | $122.4M | $168.0M |
| FCF MarginFCF / Revenue | 59.6% | 50.3% |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $437.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $367.0M | ||
| Q4 25 | $123.0M | $152.0M | ||
| Q3 25 | $78.4M | $86.0M | ||
| Q2 25 | $72.4M | $70.0M | ||
| Q1 25 | $55.4M | $59.0M | ||
| Q4 24 | $84.6M | $134.0M | ||
| Q3 24 | $-9.0M | $79.0M | ||
| Q2 24 | $67.4M | $1.0M |
| Q1 26 | — | $168.0M | ||
| Q4 25 | $122.4M | $136.0M | ||
| Q3 25 | $78.3M | $75.0M | ||
| Q2 25 | $72.4M | $58.0M | ||
| Q1 25 | $54.6M | $52.0M | ||
| Q4 24 | $84.1M | $109.0M | ||
| Q3 24 | $-9.2M | $71.0M | ||
| Q2 24 | $67.1M | $-6.0M |
| Q1 26 | — | 50.3% | ||
| Q4 25 | 59.6% | 40.7% | ||
| Q3 25 | 37.4% | 19.6% | ||
| Q2 25 | 38.5% | 14.6% | ||
| Q1 25 | 30.7% | 16.5% | ||
| Q4 24 | 46.2% | 32.4% | ||
| Q3 24 | -5.8% | 17.9% | ||
| Q2 24 | 46.2% | -1.6% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 4.8% | ||
| Q3 25 | 0.1% | 2.9% | ||
| Q2 25 | 0.0% | 3.0% | ||
| Q1 25 | 0.4% | 2.2% | ||
| Q4 24 | 0.3% | 7.4% | ||
| Q3 24 | 0.2% | 2.0% | ||
| Q2 24 | 0.2% | 1.9% |
| Q1 26 | — | — | ||
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | 0.82× | ||
| Q2 25 | 6.05× | 0.80× | ||
| Q1 25 | 22.92× | 0.97× | ||
| Q4 24 | 6.75× | 1.58× | ||
| Q3 24 | -0.96× | 0.77× | ||
| Q2 24 | 3.44× | 0.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
WH
| Fee-related and other revenues | $334.0M | 100% |
| Management and other fees | $2.0M | 1% |
